Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	52.23	10.72	29.47	19.38	9.95
Short-Term Investments	-	7.5	2.41	1.51	1.08	1.09
Trading Asset Securities	-	-	8.08	3.08	0.58	0.58
Cash & Short-Term Investments	59.73	59.73	21.21	34.05	21.04	11.62
Cash Growth	176.77%	181.69%	-37.73%	61.84%	81.16%	-62.41%
Accounts Receivable	-	1,771	648.49	345.6	902.73	410.75
Other Receivables	-	-	-	-	0.16	0.18
Receivables	-	1,776	650.95	347.11	903.79	418.19
Inventory	-	2,399	1,750	1,501	464.6	675.75
Restricted Cash	-	-	0.38	3.38	0.26	0.25
Other Current Assets	-	45.02	149.49	276.34	136.81	195.01
Total Current Assets	-	4,280	2,572	2,162	1,526	1,301
Property, Plant & Equipment	-	524.89	461.53	386.26	322.82	303.25
Long-Term Investments	-	7.53	4.66	0.03	0.03	0.03
Other Intangible Assets	-	4.27	4.2	3.08	0.56	0.27
Other Long-Term Assets	-	57.87	33.61	21.32	19.98	11.83
Total Assets	-	4,874	3,076	2,573	1,870	1,616
Accounts Payable	-	1,448	629.47	593.43	486.17	599.61
Accrued Expenses	-	-	27.98	27.47	24.45	20.53
Short-Term Debt	-	-	867.6	677.09	186.19	167.37
Current Portion of Long-Term Debt	-	1,506	59.52	33.98	-	-
Current Income Taxes Payable	-	71.16	55.35	42.9	27.91	11.26
Other Current Liabilities	-	186.83	28.36	21.7	12.79	65.8
Total Current Liabilities	-	3,212	1,668	1,397	737.5	864.56
Long-Term Debt	-	165.35	127.98	154.4	420.39	291.11
Long-Term Deferred Tax Liabilities	-	44.84	41.37	38.43	14.31	13.77
Other Long-Term Liabilities	-	38.33	12.04	9.67	7.05	6.04
Total Liabilities	-	3,460	1,861	1,609	1,189	1,185
Common Stock	-	47.22	46.99	45.32	44.33	39.9
Additional Paid-In Capital	-	-	714.27	549.69	454.12	271.55
Retained Earnings	-	-	437.73	285.48	180.04	119.26
Comprehensive Income & Other	-	1,367	15.72	83.27	2.13	-
Total Common Equity	1,414	1,414	1,215	963.76	680.61	430.7
Shareholders' Equity	1,414	1,414	1,215	963.76	680.61	430.7
Total Liabilities & Equity	-	4,874	3,076	2,573	1,870	1,616
Total Debt	1,671	1,671	1,055	865.47	606.59	458.48
Net Cash (Debt)	-1,612	-1,612	-1,034	-831.41	-585.54	-446.87
Net Cash Per Share	-365.56	-366.04	-222.73	-185.67	-141.03	-112.00
Filing Date Shares Outstanding	4.72	4.4	4.7	4.53	4.43	3.99
Total Common Shares Outstanding	4.72	4.4	4.7	4.53	4.43	3.99
Working Capital	-	1,068	903.72	765.54	788.99	436.25
Book Value Per Share	321.09	321.09	258.50	212.64	153.54	107.96
Tangible Book Value	1,410	1,410	1,211	960.68	680.05	430.43
Tangible Book Value Per Share	320.12	320.12	257.60	211.96	153.42	107.89
Land	-	-	5.24	5.24	5.24	5.24
Buildings	-	-	220.93	210.02	210.02	200.76
Machinery	-	-	391.07	289.59	198.63	167.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.